These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22094073)

  • 21. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.
    Thijssen J; van den Akker van Marle ME; Borleffs CJ; van Rees JB; de Bie MK; van der Velde ET; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):25-34. PubMed ID: 23998638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.
    Ellis CR; Dickerman DI; Orton JM; Hassan S; Good ED; Okabe T; Andriulli JA; Quan KJ; Greenspon AJ
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):658-68. PubMed ID: 26875541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of premature battery depletion in a large multicentre registry of subcutaneous cardioverter-defibrillator patients.
    Wörmann J; Strik M; Jurisic S; Stout K; Elrefai M; Becher N; Schaer B; van Stipdonk A; Srinivasan NT; Ploux S; Breitenstein A; Kron J; Roberts PR; Toennis T; Linz D; Dulai R; Hermes-Laufer J; Koneru J; Erküner Ö; Dittrich S; van den Bruck JH; Schipper JH; Sultan A; Rosenberger KD; Steven D; Lüker J
    Europace; 2024 Jul; 26(7):. PubMed ID: 38885309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.
    Landolina M; Morani G; Curnis A; Vado A; D'Onofrio A; Bianchi V; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2017 Aug; 19(8):1349-1356. PubMed ID: 27702861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs).
    Shafat T; Baumfeld Y; Novack V; Konstantino Y; Amit G
    Clin Res Cardiol; 2013 Jan; 102(1):43-9. PubMed ID: 22798033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reuse of explanted, resterilized implantable cardioverter-defibrillators: a cohort study.
    Pavri BB; Lokhandwala Y; Kulkarni GV; Shah M; Kantharia BK; Mascarenhas DA
    Ann Intern Med; 2012 Oct; 157(8):542-8. PubMed ID: 23070487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longevity of implantable electrophysiology devices explanted from patients having autopsy in hospitals.
    Zamani P; Kirkpatrick JN; Litzky LA; Verdino RJ
    Am J Cardiol; 2012 Dec; 110(11):1643-5. PubMed ID: 22939580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in implantable cardioverter defibrillator pulse generator longevity between manufacturers.
    Ellinor PT; Guy ML; Ruskin JN; McGovern BA
    Pacing Clin Electrophysiol; 2003 Jan; 26(1 Pt 1):71-5. PubMed ID: 12685143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization trends and clinical outcomes in patients implanted with a single- vs a dual-coil implantable cardioverter-defibrillator lead: Insights from the ALTITUDE Study.
    Hsu JC; Saxon LA; Jones PW; Wehrenberg S; Marcus GM
    Heart Rhythm; 2015 Aug; 12(8):1770-5. PubMed ID: 25916569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry.
    Poli S; Boriani G; Zecchin M; Facchin D; Gasparini M; Landolina M; Ricci RP; Lanera C; Gregori D; Proclemer A
    J Am Heart Assoc; 2019 Aug; 8(15):e012759. PubMed ID: 31340695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac implantable electronic device reutilization: battery life of explanted devices at a tertiary care center.
    Gakenheimer L; Romero J; Baman TS; Montgomery D; Smith CA; Oral H; Eagle KA; Crawford T
    Pacing Clin Electrophysiol; 2014 May; 37(5):569-75. PubMed ID: 24359248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators.
    Ozcan C; Rottman JN; Heist EK; Guy ML; Ellinor PT; Singh J; Milan DJ; Danik SB; Barrett CD; Mansour M; Ruskin JN; Mela T
    Heart Rhythm; 2012 May; 9(5):717-20. PubMed ID: 22172318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices.
    Briongos-Figuero S; Sánchez A; Pérez ML; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
    J Interv Card Electrophysiol; 2019 Apr; 54(3):267-275. PubMed ID: 30523511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.